Although the results of this study presented increased risks only in a small number of individual second primary cancers such as liver, lung, and brain cancers, combining these previous studies, the risks of second primary cancers were increased in the group of patients who took thyroid hormone compared to those who did not. Here, TG is linked to cancer.